Biotech investing just got a little more dangerous. Freuerstein has decided to make some changes to his "Biotech mailbag" and now call it the "Biotech notebook". "My goal here is to create a home for short, investable updates on biotech stocks -- stuff that I hear from my sources, riffs on company announcements, or even just random observations and rants.
I'd like the column to have a "bloggy" feel, so I'm going to be liberal with links. I may point out an interesting science or health story, highlight research studies, or comment on something interesting (or infuriating) posted on someone else's biotech blog".
Why do I get the feeling he's going to blast more of my stocks?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.